CompaniesByCap
GTBP
GT Biopharma, Inc. (GTBP)
NASDAQ · Healthcare

GT Biopharma, Inc. Cash Flow 2010–2020

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010
Operating Activities
Operating Cash Flow-12.9M-12.9M-8.9M-15.2M-15.6M-7.3M-3.7M-10.7M-5.4M-1.9M-4.7M-1.7M-442,000-987,000-963,000-1.5M
Depreciation & Amort.
Investing Activities
Capital Expenditure036,0004,00001,0006,00002,0000
Free Cash Flow-3.7M-10.7M-5.4M-1.9M-4.7M-1.8M-442,000-989,000-963,000
Financing Activities
Dividends Paid229,000
Stock Buybacks

GT Biopharma, Inc. Cash Flow — FAQ

GT Biopharma, Inc. (GTBP) cash flow over the last 10 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see GTBP's cash flow history?

The chart and table above show GT Biopharma, Inc.'s cash flow by year and by quarter, including the growth rate.